Neoadjuvant endocrine therapy with sequential palbociclib and chemotherapy based on Ki67 status in stage II-III breast cancer: An open-label, phase II study
Year: 2025
Type: article
Language: en
Topic: Advanced Breast Cancer Therapies
Authors and affiliations:
raw_author_name: Christina Engebrethsen
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Synnøve Yndestad
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Mari E. Rasmussen
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Emiel A.M. Janssen
raw_affiliation_strings: Department of Pathology, Stavanger University Hospital, Stavanger, Norway; Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway; Institute for Biomedicine and Glycomics, Griffith University, Queensland, Australia
raw_author_name: Bjørnar Gilje
raw_affiliation_strings: Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway
raw_author_name: Egil S. Blix
raw_affiliation_strings: Immunology Research Group, Institute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway; Department of Oncology, University Hospital of North Norway, Tromsø, Norway
raw_author_name: Helge Espelid
raw_affiliation_strings: Department of Surgery, Haugesund Hospital, Haugesund, Norway
raw_author_name: Steinar Lundgren
raw_affiliation_strings: Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
raw_author_name: Jürgen Geisler
raw_affiliation_strings: Department of Oncology, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway
raw_author_name: Laura Minsaas
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Reidun Lillestøl
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Hildegunn S. Aase
raw_affiliation_strings: Department of Radiology, Haukeland University Hospital, Bergen, Norway
raw_author_name: Turid Aas
raw_affiliation_strings: Department of Surgery, Haukeland University Hospital, Bergen, Norway
raw_author_name: Per E. Lønning
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Hans P. Eikesdal
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway
raw_author_name: Stian Knappskog
raw_affiliation_strings: Department of Clinical Science, University of Bergen, Bergen, Norway; Cancer Clinic, Haukeland University Hospital, Bergen, Norway. Electronic address: Stian.Knappskog@uib.no